Open Access

Osteocalcin, osteopontin and RUNX2 expression in patients with arteriosclerosis

  • Authors:
    • Jörg Ukkat
    • Cuong Hoang-Vu
    • Bogusz Trojanowicz
    • Artur Rebelo
  • View Affiliations

  • Published online on: April 21, 2021     https://doi.org/10.3892/wasj.2021.103
  • Article Number: 32
  • Copyright: © Ukkat et al. This is an open access article distributed under the terms of Creative Commons Attribution License.

Metrics: Total Views: 0 (Spandidos Publications: | PMC Statistics: )
Total PDF Downloads: 0 (Spandidos Publications: | PMC Statistics: )


Abstract

Knowledge of the role of the skeleton as an endocrine organ has increase over the past years. The role of calcification in arteriosclerotic disease has also been a matter of investigation. Since there is a clear association between the levels of osteocalcin (OC), osteopontin (OPN) and Runt‑related transcription factor 2 (RUNX2) and the development of arteriosclerotic vascular disease, the present study examined the expression of OC, OPN and RUNX2 in vascular tissue and their possible employment as diagnostic markers for cardiovascular disease. For this purpose, 13 vessel tissues, including tissues from six patients without arteriosclerotic disease (PAD‑) and 7 patients with arteriosclerotic disease (PAD+) were obtained by surgical resection. Immunohistochemistry and reverse transcription‑quantitative polymerase chain reaction (RT‑qPCR) analysis were performed. The results revealed that tissues representing PAD+ exhibited a noticeably stronger protein expression of OC, OPN and RUNX2 as compared with the corresponding PAD‑ tissues. The transcript levels of OPN and RUNX2 were associated with protein expression and were significantly elevated in PAD+ (OPN, P<0.05; RUNX2, P<0.01). The expression of OC in PAD+ was noticeably increased as compared with PAD‑ (P=0.067). On the whole, the present study demonstrates that the expression of OC, OPN and RUNX2 in arterial tissue is strongly associated with symptomatic arteriosclerotic disease. Further investigations are required however, to prove the tge clinical significance of OC, OPN and RUNX2 as potential biomarkers for atherosclerotic disease.
View Figures
View References

Related Articles

Journal Cover

May-June 2021
Volume 3 Issue 3

Print ISSN: 2632-2900
Online ISSN:2632-2919

Sign up for eToc alerts

Recommend to Library

Copy and paste a formatted citation
x
Spandidos Publications style
Ukkat J, Hoang-Vu C, Trojanowicz B and Rebelo A: Osteocalcin, osteopontin and RUNX2 expression in patients with arteriosclerosis. World Acad Sci J 3: 32, 2021
APA
Ukkat, J., Hoang-Vu, C., Trojanowicz, B., & Rebelo, A. (2021). Osteocalcin, osteopontin and RUNX2 expression in patients with arteriosclerosis. World Academy of Sciences Journal, 3, 32. https://doi.org/10.3892/wasj.2021.103
MLA
Ukkat, J., Hoang-Vu, C., Trojanowicz, B., Rebelo, A."Osteocalcin, osteopontin and RUNX2 expression in patients with arteriosclerosis". World Academy of Sciences Journal 3.3 (2021): 32.
Chicago
Ukkat, J., Hoang-Vu, C., Trojanowicz, B., Rebelo, A."Osteocalcin, osteopontin and RUNX2 expression in patients with arteriosclerosis". World Academy of Sciences Journal 3, no. 3 (2021): 32. https://doi.org/10.3892/wasj.2021.103